C. Giraud

E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.

S. Truant, F. Pruvot, F. Révillion, 2009, European journal of cancer.

Assessment of Baseline Clinical Predictive Factors of Response to Cetuximab-Irinotecan in Patients with Irinotecan-Refractory Metastatic Colorectal Cancer

T. Conroy, C. Fournier, O. Bouché, 2008, Oncology.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

P. Couzigou, M. Ducreux, C. Borel, 2018, European journal of cancer.

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

C. Tournigand, M. Espié, B. Weber, 2019, The Lancet.

Response to ado-trastuzumab emtansine according to RANO criteria in central nervous system metastases of HER2 positive breast cancers.

J. Bonneterre, C. Giraud, E. Rhun, 2016 .